objectives Rotaviruses are the most common cause of severe diarrhoeal disease in young children. conclusions RVA was one of the major aetiological agents of diarrhoeal children in Chengdu. Genotype distribution differed within each year and the gene analysis implied low efficacy of LLR. Continuous epidemiological monitoring of RVA is essential for the national vaccination programme.
Introduction
Diarrhoeal disease is the second leading cause of death in children under 5 years of age, and rotaviruses (RVs) are the most common cause of severe diarrhoeal disease in young children globally [1, 2] . RV infections may lead to severe dehydration, electrolyte disorders and acid-base disturbances [3] . According to a WHO estimate, in 2013, RV caused 3191 deaths of children under five in China and accounted for 35.2% of total deaths from diarrhoea. In 2008, China ranked 23rd among 193 nations in terms of RV-caused deaths; by 2013, it had risen to 15th among 194 nations [4] .
RVs are members of the Rotavirus genus of the Reoviridae family, which consists of viruses with segmented, double-stranded RNA (dsRNA) genomes. The virion consists of a triple-layered protein capsid containing 11 segments of dsRNA encoding six structural proteins (VP1-VP4, VP6 and VP7) and five or six nonstructural proteins (NSP1-NSP6). On the basis of their distinct antigenic and genetic properties, RVs are classified into nine species commonly referred to as group A-I according to International Committee on Taxonomy of Viruses (ICTV). Of these, group A (RVA) causes most infections in young children. RVs have been classified into different genotypes based on the sequences of VP7 (G-type antigen) and VP4 (P-type antigen) [5] [6] [7] . The RVA species comprises at least 27 G types and 37 P types [8] , and the most common strains were G1P [8] , G2P [4] , G3P [8] and G9P [8] across Asia [9] .
No specific drug to treat rotavirus is available, so vaccination is considered the most efficient way to control rotavirus gastroenteritis [10] . According to WHO, about 215 000 children aged <5 years die each year from *Contributed equally.
vaccine-preventable rotavirus infections [2] . So far, two oral, live, attenuated rotavirus vaccines, Rotarix TM (derived from a single strain of human rotavirus, G1P [8] ) and RotaTeq TM (containing five reassortant bovine-human rotavirus, G1-4P [5] and G6P [8] ), are available internationally and WHO-prequalified. They were introduced in 90 countries and the global coverage (two doses for Rotarix; three doses for RotaTeq) was estimated at 25% by the end of 2016 [2, 11, 12] . However, only Lanzhou lamb rotavirus vaccine produced by Lanzhou Institute of Biological Products Co., Ltd (LLR) has been available in China for 18 years, but its efficacy has rarely been investigated [13] . LLR vaccination coverage (one dose) in Guangzhou, China, was relatively low compared to global coverage at 25.3% from 2008 to 2012; only 0.5% of children received three doses [14] . The genotype of LLR is G10P [12] [15] , different from the prevalent genotypes in Asia [9] . Manufacturers are now applying for licensure of Rotarix and RotaTeq in China, and more rotavirus vaccines are being developed locally [10] .
Chengdu, the central city of West China, differs from East China in terms of economy, climate feature and health facilities. Little is known about the clinical and epidemiological profile of RVA in children with acute diarrhoea or the efficacy of LLR in Chengdu. Therefore, this study aimed to determine the prevalence and clinical profile of RVA infection in diarrhoeal children and to compare the similarity of predominant RVA strains in Chengdu and other parts of China with three vaccines. Our results can provide evidence for the vaccination programmes in Chengdu.
Materials and methods

Sample collection
The study was approved by the ethics committee of Sichuan University, and written informed consent was obtained from parents or caregivers before samples were collected. All cases were enrolled according to the same inclusion criteria: (i) children under 15 years of age, (ii) presenting with diarrhoea and (iii) treated at surveillance hospitals in Chengdu between September 2009 and February 2014. Diarrhoea was defined as three or more stools per day of unusual stool shape (liquid, watery, mucous or bloody purulent) within the previous 24 h according to the Global Enteric Multicenter Study (GEMS).
Virus detection and genotyping
Fresh stool was collected after enrolment of outpatients with a commercial virus sampling tube. Samples were transferred to the pathogen laboratory within 2 h and stored at À80°C. Viral RNA was extracted (Geneaid Biotech, Taiwan, China), and the first strand cDNA was synthesised from the extracted viral RNA using a commercial kit (Bio-Rad, USA). Hemi-nested type specific multiplex PCRs were performed to detect RVA and its VP4 and VP7 genes for the determination of G and P genotypes. Six G types (G1, G2, G3, G4, G8 and G9) and six P types (P [4] , P [6] , P [8] , P [9] , P [10] and P[11]) were detected (see Table S1 for primers information [16, 17] and Table S2 for PCR parameters). G and P genotypes were classified according to amplicon size visualised under ultraviolet light after electrophoresis on 2% agarose gels stained with GoldView (Solarbio, Beijing, China).
Sequencing and phylogenetic analysis
The complete VP7 genes of eight positive samples including subtypes G1, G3, G9 and VP4 genes of seven positive samples including subtypes P [4] , P [8] were amplified (see Table S1 for primers information [18] and Table S3 for PCR parameters) and purified using Wizard SV Gel and PCR Clean-Up System (Promega, Madison, WI) and then sequenced by Invitrogen Company for further molecular analysis. Sequences of VP7 and VP4 were submitted to GenBank under accession numbers MG816515-MG816529. The neighbour-joining (NJ) trees of RVA VP4/VP7 genes were established with the Maximum Composite Likelihood method using MEGA 6.0 software. Bootstrap values were determined for 1000 repetitions.
Demographic and clinical parameters and climatic variables
Demographic data were obtained by a standardised questionnaire and clinical information was collected from the database. Other acute gastroenteritis viruses, such as enteric adenovirus (EADV), human astrovirus (HAstV), norovirus (NoV) and Sapporo-like Virus (SLV) were detected by PCR following the Standard Operating Procedure (SOP) of the Chinese National Technical Platform for Communicable Disease Surveillance Project [19] . Monthly temperatures (minimum and maximum) from January 2011 to February 2014 were obtained from the Central Meteorological Bureau [20] . (Table 1) . Four samples were coinfected with more than two viruses. As shown in Figure 2a , RVA was detected throughout the year during the study period. The positive rate peaked in winter (from December to February) but was low in summer (from June to August) (30.7% vs. 9.4%, P < 0.001). However, the positive rate in winter differed every year (P = 0.001), being lowest in 2011-2012 at 17.2% and highest in 2013-2014 at 51.2%. The average minimum and maximum seasonal temperature and RVApositive rates from January 2011 to February 2014 are shown in Figure S1 . The monthly positive rate of RVA correlated with both minimum and maximum monthly temperature (r = À0.406, P = 0.012; r = À0.390, P = 0.015), whereas the positive rate of acute gastroenteritis viruses did not (P = 0.148, P = 0.182).
Demographics
The included outpatients were aged 0-14 years. Median age was 9 months in all outpatients, 8 months in virusnegative, 11 months in virus-positive and 1 year in RVApositive outpatients. The median age of children infected with RVA was older than those without (P < 0.001). The ratio of male to female was 1.44:1 (662:459). The detection rate of total viruses and RVA in males was higher than in females, but without statistical significance (36.9% vs. 34.0%, P = 0.324; 17.8% vs. 17.0%, P = 0.719) (details in Table 2 ). RVA was detected in a wide age range (27 days to 14 years). 61.2% (686/1121) of diarrhoeal outpatients were less than 1 year old, which accounted for 50% (98/196) of RVA-positive patients. Both virus-positive rate and RVA-positive rate dropped after 1 month of age, rose between 1 month and 2 years of age and peaked at 2 years of age (Figure 2b) . No significant differences were observed among infants aged 1-11 months (P = 0.059), but the positive rate at 1 year of age was higher than at 1-11 months (21.1% vs. 14.3%, P = 0.030).
Clinical features
Symptoms such as diarrhoeal frequency, fever, vomit, respiratory disease and test results for white blood cell count (WBC) and red blood cell count (RBC) in stool are shown in Table 2 . Of the 196 RVA-positive patients, 112 vomited, 18 had fever and 37 were diagnosed with respiratory disease (i.e. bronchitis, tonsillitis, upper respiratory tract infection). Compared with RVA-negative cases, RVA-positive cases vomited significantly more often (57.1% vs. 32.5%, P < 0.001). All four children coinfected with more than two viruses vomited. The positive rate of stool WBC was significantly lower in children with RVA than in those without (9.2% vs. 16.5%, P = 0.023). Children with RVA monoinfections also had a significantly lower positive rate of stool WBC than those with RVA coinfection (6.9% vs. 18.9%, (Table 3) , outpatients in winter had significantly higher frequencies of fever (17.9% vs. 0%, P = 0.012) and respiratory disease (26.8% vs. 5.9%, P = 0.014). Frequency of vomiting and positive stool WBC was also higher in winter but not significant.
Phylogenetic analysis
To determine the similarity of predominant RVA strains in China with three vaccines, the complete genes of VP4 and VP7 of 13 RVA strains were sequenced and compared with the sequences available at GenBank. Sequences of vaccines and other available sequences of RVA strains circulating in China and abroad used for phylogenetic analysis are listed in Table S4 . Phylogenetic analysis of the VP7 nucleotide sequences showed that the strains in our study were similar to strains circulating in Liaoning, Yunnan, Hubei, Hebei, Beijing, north, southwest and central China (Figure 3a) . Rotarix vaccine shared high identities with domestic G1 strains. RotaTeq vaccine also shared relatively high identities with the major genotypes of domestic strains and was relatively closely related to them. LLR vaccine, however, differed from domestic strains and shared low identities. Phylogenetic analysis of the VP4 nucleotide sequences showed similar results in that both Rotarix and RotaTeq vaccines shared high identities to domestic P [8] strains and were more closely related to P [4] than LLR vaccine (Figure 3b) . rate in Chengdu was much lower than the global median rate but much higher than that in Chile, 7%. Twenty years ago the RVA-positive rate in Chengdu was almost 10% higher [22] . However, the study 20 years ago ran over a short period of only 3 months from October 1998 to January 1999 and mainly in winter, which may have resulted in a higher detection rate. The RVA-positive rate in our study was higher than in Beijing, which was 12.59% from 2011 to 2014 [19] . The variation in detection rates between studies may be related to study period, patient inclusion/exclusion criteria, climate or economic status [6] . The main identified G and P genotypes of RVA were G1 and P [8] and G1P [8] was the most prevalent genotype from 2009 to 2013, except for 2 months in 2014, when the dominant genotype was G9P [8] -similar to Kunming, China, where from February 2015 to January 2016 G9P [8] strains accounted for 79.4% of all RVA strains [3] . The distribution of G9 strains has increased worldwide in recent years, including Uganda [23] , Turkey [24] and Cambodia [25] . Hence, the trend of RVA genotype distribution in Chengdu was similar to national and global trends in that G9P [8] may be the next predominant strain after G1P [8] . This raises concern, as available vaccines so far do not include this genotype.
In this study, 18.88% of RVA-positive cases were codetected with other gastroenteritis viruses including NoV, EADV, HAstV and SLV. Similar multiviral detection rates were reported in Beijing (15.1%) and Shanghai (14.9%) [19, 26] . Diarrhoea frequency in the RVA coinfected group was higher than in RVA-monoinfected patients. In Turkey, multiple viral agents were detected in 29% of virus-positive patients, all of whom were hospitalised. Duration of hospitalisation was also longer in multiply infected children [27] .
Multiviral infection accounts for a certain proportion of all infections and causes more severe clinical manifestation. As RVs were often present in patients who had mixed infections [28] , it is important to implement vaccination in children and to treat them early.
RVA was detected throughout the year and followed a seasonal distribution, similar to previous reports in which peaks were observed in the winter months [29] [30] [31] . Nafissatou et al. 5 years of age were correlated with temperature (r = À0.68, P = 0.01) [32] , and our study also found a negative correlation between RVA-positive rate and temperature. As the total positive rate of acute gastroenteritis viruses had no correlation with temperature, it could not be the bacteria-induced food poisoning in summers that raised the total number of included diarrhoea outpatients which resulted in lower RVA-positive rates in winters. Thus, the temporal distribution of RVA may due to the inhibition of viral RNA synthesis caused by heat, which correlated with a loss of rotavirus infectivity [32] . In that case, more attention should be paid to RVA screening and detection in winter, especially the cold months.
Regarding age distribution of RVA, the detection rate was at its peak (34.62%) in the second year of life and the RVA-positive rate of one-year-old diarrhoeal outpatients was higher than at 1-11 months of age (P = 0.030). This corroborates the finding of Matthew et al. that hospitalisation for RVs gastroenteritis occurred most frequently in children between 6 and 24 months of age [29] . The low positive rate at 1-11 months may be ascribed to the protection of breastfeeding [33] . It is important to control RVA infection in children less than 2 years old through public health interventions such as promotion of breastfeeding and vaccination.
In the 196 RVA-positive cases, clinical symptoms included vomiting (112/196, 57.14%), fever (18/196, 9 .18%) and respiratory symptoms (37/196, 18 .88%), median diarrhoea frequency (5 times/day). We found that vomiting (57.1% vs. 32.6%, P < 0.001) was more frequent in RVA-positive patients but saw no significant differences in fever, respiratory symptoms or diarrhoea frequency. Similar results were found in a multisite birth cohort: 54% of RVs diarrhoeal episodes were associated with vomiting, 5.4% with fever [34] . A study in Bolivia also found no significant difference of diarrhoea frequency between NoV-positive and RVA-positive children aged 5-24 months [35] . However, in India and Republic of Congo, both vomiting and fever were significantly more commonly associated with RVA-positive cases [33, 36] , which may be because the study in India used ELISA to detect rotavirus and the study in Congo only included hospitalised children. We also found that outpatients in winter had significantly higher frequencies of fever and respiratory diseases than in summer, indicating RVA may be more virulent at low temperatures, which is partly consistent with the high temperature-caused loss of infectivity [32] . However, the relation between temperature and virulence has rarely been discussed and needs further study. But it does highlight the importance of putting greater emphasis on RVA detection in winter.
Routine stool examination was performed in this study, which was rare in other studies. The detection rate of WBC was 16.54% in RVA-negative, 6.92% in RVAmono-infected and 18.92% in RVA-coinfected samples. WBC were much less frequently detected in RVA-monoinfected stools than in RVA-negative (6.9% vs. 16.5%, P = 0.002) and RVA-coinfected samples (6.9% vs. 18.9%, P = 0.009). In Taiwan, WBC counts in stools of RVA-positive cases were significantly lower than those of NoV-positive cases [37] , which was consistent with our study. WBC in stool is one of the parameters assessing severity of acute diarrhoea in adult patients and suggestive of inflammatory diarrhoea [38] . Multiviral diarrhoea should be prevented through early treatment as the WBC-positive rate of RVA-coinfected samples was nearly triple that of RVA-mono-infected samples.
We also compared the similarity of predominant RVA strains in China with three globally available vaccines, RotaTeq, Rotarix and LLR. LLR proved to share low identity to domestic strains. A study in Kunming, China also found the amino acid sequence of dominant G9P [8] strains to be closely related to RotaTeq but showing a low degree of homology with LLR [3] . A randomised, double-blind, placebo-controlled multicentre trial in healthy Chinese infants indicated that RotaTeq was efficacious against any severity and severe rotavirus gastroenteritis caused by any serotype and generally welltolerated [39] . An economic evaluation to forecast the potential impacts of the two international vaccines compared to domestic LLR found that Rotateq and Rotarix significantly decreased incidence compared to LLR, particularly among infants aged 6 months to 2 years [15] . The time may have come to reconsider the vaccination programme in China and introduce new vaccines as described in 'the integrated Global Action Plan for Pneumonia and Diarrhoea' by WHO/UNICEF [40] .
Unfortunately, the RVA genotypes in this study were determined by PCR rather than sequencing, which limited their identification. Not all samples were successfully genotyped, and only G1, G2, G3, G4, G8, G9 and P [4] , P [6] , P [8] , P [9] , P[10] P[11] were identified. As the cost of sequencing was high and predominant prevalent G and P genotypes were included [9] , our study did the laboratory work as the request of Technical Platform for Communicable Disease Surveillance Project.
In conclusion, we described the epidemiological characteristics and clinical features of RVA in children with acute diarrhoea in Chengdu, China. As the most frequently detected virus, RVA was identified in 17.48% of 1121 faecal specimens and 18.88% of the RVA-positive samples were coinfected with other acute gastroenteritis viruses. RVA was mostly detected in winter and in children 1-2 years of age. G1P [8] and G9P [8] were the dominant RVA genotype strains in the Chengdu area. Phylogenetic analysis revealed that the genotypes of Rotarix and RotaTeq vaccines are consistent with RVA strains prevalent in Sichuan and share high identity, whereas LLR showed low efficacy. Further comparisons of the effectiveness of vaccines are necessary before they are applied in China.
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